No Data
Insider Sale: See Remarks of $AURA (AURA) Sells 15,955 Shares
Why Check-Cap Shares Are Trading Higher By Over 52%; Here Are 20 Stocks Moving Premarket
Buy Recommendation for Aura Biosciences Inc. Based on Promising Clinical Data and Growth Prospects
Aura Biosciences Price Target Lowered to $21 From $23 at JMP Securities
Muscle Invasive Bladder Cancer Drug Pipeline Market Research 2024 Featuring Aura Biosciences, Janssen Research & Development, Asieris Pharmaceuticals, and RemeGen
Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx Conference
